
# Albumin Binding Analysis Report
Generated: 2025-07-24 13:58:10

## Dataset Summary
- Total Type 1 EGFR inhibitors analyzed: 2,242
- LogP range: -1.38 - 3.60
- Average albumin binding: 58.5%

## Albumin Binding Distribution
- Low: 1666 compounds (74.3%)
- Low-Medium: 576 compounds (25.7%)

## LogP ≤ 3.6 Optimization Results
- High albumin binders before filter: 1.2%
- High albumin binders after filter: 0.0%
- **Reduction achieved: 100.0%** (✅ Target achieved)

## Property Correlations
- LogP vs Albumin Binding: r = 0.921
- TPSA vs Albumin Binding: r = -0.593
- MW vs Albumin Binding: r = -0.035

## Key Insights
1. **LogP optimization successful**: 100% reduction in high albumin binders
2. **Optimal LogP range**: 1.5-3.0 for balanced permeability and albumin binding
3. **TPSA importance**: Higher TPSA correlates with lower albumin binding
4. **Pharmacokinetic balance**: Top 50 compounds identified for optimal PK properties

## Recommendations
1. Maintain LogP ≤ 3.6 filter for albumin binding optimization
2. Target LogP range 2.0-3.0 for best balance
3. Consider TPSA ≥ 70 Ų for reduced albumin binding
4. Prioritize compounds in 'Low' and 'Low-Medium' albumin binding categories
